Midbrain cytotoxic T cells as a distinct neuropathological feature of progressive supranuclear palsy

Progressive supranuclear palsy (PSP) is a neurodegenerative disorder characterized by four-repeat (4R) tau protein deposition. The substantia nigra (SN) and midbrain tegmentum nuclei (MBT) are consistently affected. Lymphocyte infiltrates are scarce in the brains of patients with neurodegenerative diseases, although a few reports have described their presence in the α-synucleinopathy Parkinson's disease (PD). To evaluate the cytotoxic T-cell response, serial sections spanning 120 μm of the SN were immunostained consecutively for phosphorylated tau (p-tau, AT8) or α-synuclein, cytotoxic T-cell marker and microglia marker HLA-DR. Sections were analysed with stereology software in 9 patients with PSP, 10 with PD and 6 healthy controls. We semiquantitatively scored CD8-positive cells in further brain regions. CD8 lymphocyte cell counts and microglial activation in the SN were higher in PSP than PD and controls. Furthermore, T-cell/neuron contact was observed in PSP. In multivariate models, CD8 counts were not predicted by disease duration, younger age at death or the amount of p-tau pathology. The SN and midbrain tegmentum showed more CD8 cells than the cortex. A more prominent nigral cytotoxic T-cell response in PSP than PD supports the suggestion that p-tau neuropathology in PSP might have potential relationships with autoimmune mechanisms.

Authors

Institutions

Publication Details

Journal
Brain
Published
2025-04-15
DOI
https://doi.org/10.1093/brain/awaf135
Citations
7
Primary Topic
Parkinson's Disease Mechanisms and Treatments
Type
article
Field-Weighted Citation Impact
9.72

Funders

Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Midbrain cytotoxic T cells as a distinct neuropathological feature of progressive supranuclear palsy

Anthony E. Lang, Gábor G. Kovács, Conor Fearon, Maria Carmela Tartaglia et al.
7 citations
Brain
Parkinson's Disease Mechanisms and Treatments
9.72
article

Midbrain cytotoxic T cells as a distinct neuropathological feature of progressive supranuclear palsy

Anthony E. Lang, Gábor G. Kovács, Conor Fearon, Maria Carmela Tartaglia, Seojin Lee, Susan Helen Fox, Shelley L. Forrest, Blas Couto, Samantha Knott, Jun Li
article en
7 citations

Abstract

Progressive supranuclear palsy (PSP) is a neurodegenerative disorder characterized by four-repeat (4R) tau protein deposition. The substantia nigra (SN) and midbrain tegmentum nuclei (MBT) are consistently affected. Lymphocyte infiltrates are scarce in the brains of patients with neurodegenerative diseases, although a few reports have described their presence in the α-synucleinopathy Parkinson's disease (PD). To evaluate the cytotoxic T-cell response, serial sections spanning 120 μm of the SN were immunostained consecutively for phosphorylated tau (p-tau, AT8) or α-synuclein, cytotoxic T-cell marker and microglia marker HLA-DR. Sections were analysed with stereology software in 9 patients with PSP, 10 with PD and 6 healthy controls. We semiquantitatively scored CD8-positive cells in further brain regions. CD8 lymphocyte cell counts and microglial activation in the SN were higher in PSP than PD and controls. Furthermore, T-cell/neuron contact was observed in PSP. In multivariate models, CD8 counts were not predicted by disease duration, younger age at death or the amount of p-tau pathology. The SN and midbrain tegmentum showed more CD8 cells than the cortex. A more prominent nigral cytotoxic T-cell response in PSP than PD supports the suggestion that p-tau neuropathology in PSP might have potential relationships with autoimmune mechanisms.

BrainVol. 148(8)
University Health Network (CA), Consejo Nacional de Investigaciones Científicas y Técnicas (AR), University of Toronto (CA), Favaloro University (AR), Toronto Western Hospital (CA), Mater Misericordiae University Hospital (IE), Occupational Cancer Research Centre (CA), Instituto de Neurología Cognitiva (AR), Ontario Brain Institute (CA)
Eli Lilly and Company, Biogen, Johns Hopkins University, Fondation Brain Canada, Multiple System Atrophy Coalition, University of Cambridge, Eisai, Krembil Foundation, Novo Nordisk, Parkinson Canada, Sun Pharma, Rossy Foundation, National Institutes of Health, Parkinsonfonden, Canadian Institutes of Health Research
Good health and well-being
Openalex Percentile: Top 2%
Parkinson's Disease Mechanisms and Treatments
9.72
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.